Otc - Active Ingredient
Active ingredients
Tetrahydrozoline HCl 0.05%
Zinc sulfate 0.25%
The following Structured Product Label (SPL) was submitted to the FDA by Kc Pharmaceuticals, Inc. for the product Medics Choice Eye Drops Seasonal Relief (NDC 55651-024). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - purpose, indications & usage, warnings, otc - ask doctor, otc - when using, otc - stop use, otc - pregnancy or breast feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active ingredients
Tetrahydrozoline HCl 0.05%
Zinc sulfate 0.25%
Purposes
Tetrahydrozoline HCl.....Redness reliever
Zinc sulfate...............Astringent
Use
■ for temporary relief of discomfort and redness of the eye due to minor eye irritations
Warnings
For external use only
Ask a doctor before use if you have narrow angle glaucoma
When using this product
■ pupils may become enlarged temporarily
■ to avoid contamination, do not touch tip of container to any surface. Replace cap after using.
■ if solution changes color or becomes cloudy, do not use
■ overuse may produce increased redness of the eye
■ remove contact lens before using
Stop use and ask a doctor if you experience
■ eye pain
■ changes in vision
■ continued redness or irritation of the eye, or if the condition worsens or persists for more than 72 hours
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center
(1-800-222-1222) right away.
Directions
instill 1 to 2 drops in the affected eye(s) up to 4 times daily
Other information
store at 15°-30°C (59°-86°F)
Inactive ingredients
benzalkonium chloride, boric acid, edetate disodium, purified water, sodium chloride, sodium citrate
* Please review the disclaimer below.